UNLABELLED: (123)I-N-ω-fluoropropyl-2β-carboxymethoxy-3β-(4-iodophenyl)nortropane ((123)I-FP-CIT) is commonly used to assess the dopamine transporter in the striatum. However, recent studies suggest that this tracer may be used also to assess binding to monoamine transporters in the midbrain or diencephalon, which may reflect predominantly serotonin transporter (SERT) binding. However, it is still unclear at what time point after injection SPECT should be performed for optimal assessment of SERT with(123)I-FP-CIT. Therefore, we examined the time course of extrastriatal (123)I-FP-CIT binding. METHODS: Nineteen healthy, male subjects were included, and SPECT images were acquired up to 3 h after (123)I-FP-CIT injection. Region-of-interest analysis was performed, and specific-to-nonspecific binding ratios were calculated. RESULTS: Specific-to-nonspecific (123)I-FP-CIT binding ratios in the midbrain and diencephalon were significantly higher 2 h after injection than 1 h after injection and remained stable between 2 and 3 h after injection. CONCLUSION: The optimal time frame for assessing (123)I-FP-CIT binding to extrastriatal SERT is between 2 and 3 h after injection of the tracer.
UNLABELLED: (123)I-N-ω-fluoropropyl-2β-carboxymethoxy-3β-(4-iodophenyl)nortropane ((123)I-FP-CIT) is commonly used to assess the dopamine transporter in the striatum. However, recent studies suggest that this tracer may be used also to assess binding to monoamine transporters in the midbrain or diencephalon, which may reflect predominantly serotonin transporter (SERT) binding. However, it is still unclear at what time point after injection SPECT should be performed for optimal assessment of SERT with(123)I-FP-CIT. Therefore, we examined the time course of extrastriatal (123)I-FP-CIT binding. METHODS: Nineteen healthy, male subjects were included, and SPECT images were acquired up to 3 h after (123)I-FP-CIT injection. Region-of-interest analysis was performed, and specific-to-nonspecific binding ratios were calculated. RESULTS: Specific-to-nonspecific (123)I-FP-CIT binding ratios in the midbrain and diencephalon were significantly higher 2 h after injection than 1 h after injection and remained stable between 2 and 3 h after injection. CONCLUSION: The optimal time frame for assessing (123)I-FP-CIT binding to extrastriatal SERT is between 2 and 3 h after injection of the tracer.
Authors: Karin Eva Koopman; Jan Booij; Eric Fliers; Mireille Johanna Serlie; Susanne Eva la Fleur Journal: Mol Metab Date: 2013-08-07 Impact factor: 7.422
Authors: Walter Koch; Marcus Unterrainer; Guoming Xiong; Peter Bartenstein; Markus Diemling; Andrea Varrone; John C Dickson; Livia Tossici-Bolt; Terez Sera; Susanne Asenbaum; Jan Booij; Ozlem L Kapucu; Andreas Kluge; Morten Ziebell; Jacques Darcourt; Flavio Nobili; Marco Pagani; Swen Hesse; Thierry Vander Borght; Koen Van Laere; Klaus Tatsch; Christian la Fougère Journal: Eur J Nucl Med Mol Imaging Date: 2014-05-08 Impact factor: 9.236
Authors: E Zoons; M A J Tijssen; Y E M Dreissen; J D Speelman; M Smit; J Booij Journal: Eur J Nucl Med Mol Imaging Date: 2017-03-17 Impact factor: 9.236
Authors: Anke J Borgers; Anneke Alkemade; Elsmarieke M Van de Giessen; Madeleine L Drent; Jan Booij; Peter H Bisschop; Eric Fliers Journal: EJNMMI Res Date: 2013-04-25 Impact factor: 3.138
Authors: Sven R Suwijn; Henk W Berendse; Constant Vm Verschuur; Ania Winogrodzka; Rob Ma de Bie; Jan Booij Journal: EJNMMI Res Date: 2013-06-05 Impact factor: 3.138
Authors: Merijn Joling; Chris Vriend; Jessica J van der Zande; Afina W Lemstra; Odile A van den Heuvel; Jan Booij; Henk W Berendse Journal: Neuroimage Clin Date: 2018-04-06 Impact factor: 4.881